SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-13-000735
Filing Date
2013-03-12
Accepted
2013-03-12 16:37:37
Documents
1
Period of Report
2013-03-06

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP q13-00353.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP q13-00353.xml 4 8344
  Complete submission text file 0001387131-13-000735.txt   9838
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 1176 RANCHO SANTA FE CA 92067
Business Address
CARLO DENNIS J PHD (Reporting) CIK: 0001038322 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26372 | Film No.: 13684637